Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
German drugmaker Boehringer Ingelheim's turnover in Hungary edged down 0.6% to HUF 10.9 billion in 2012, managing director Gábor Zalai said at a press conference on Tuesday. Boehringer Ingelheim's market share came to 1.9%, making it the 17th biggest player. This year, the company expects sales to stagnate, Zalai said.